Social Determinants of Health in Glioblastoma Population
Completed
Conditions studied: Glioma, Astrocytoma, Oligodendroglioma, Ependymoma, Ganglioglioma, Pleomorphic Xanthoastrocytoma
In brief
The overall aim of this study is to prospectively characterize social health disparities in a cross-sectional cohort of glioma patients with attention to exploring and thematically categorizing the patient-specific and community-level factors. This will be conducted in two parts.
Key facts
- Study ID
- NCT03900689
- Run by
- Wake Forest University Health Sciences
- People needed
- 100
- Starts
- 2019-05-22
- Expected to finish
- 2022-03-27
- Last updated by the study team
- 2026-08-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Part 1:
- Adults who are 18 years or older
- Have a histologically confirmed glioma of any grade (WHO Grade 2-4: astrocytoma, oligodendroglioma, ependymoma, ganglioglioma, pleomorphic xanthroastrocytoma)
- Currently receiving primary oncologic care at Wake Forest Baptist Comprehensive Cancer Center
- Have the ability to speak and read either English or Spanish.
- Ability to provide informed consent
- Part 2:
- Participants who participated in Part 1 and express willingness to be contacted about Part 2
- Ability to provide informed consent
- Ability to speak and understand English
- Inclusion of Women and Minorities (for Part 1 and Part 2)
- Women of all races and ethnicity who meet the above-described eligibility criteria are eligible for this trial.
You may not qualify if…
- Patients who are unable to read or complete the required study-related forms. Patients who are unable to read but can be assisted by a proxy or family member will be included.
Where it is running
- Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.